General Western Blot Reagents
Abcam Marimastat, Matri x metalloprotease (MMP) inhibitor, 10MG
MW 331.41 Da, Purity >98%. Potent matrix metalloproteinase inhibitor. Broad-spectrum inhibitor of all major MMPs. Prevents or reduces spread and growth of tumors.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Clindamycin, inhibits protein synthesis, 50MG
MW 425 Da, Purity >99%. Broad spectrum antimicrobial agent. Active against Gram-positive and Gram-negative bacteria and selected protozoa. Competitive inhibitor of peptide formation in large 50S ribosomal unit. Orally active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Clindamycin, inhibits protein synthesis, 10MG
MW 425 Da, Purity >99%. Broad spectrum antimicrobial agent. Active against Gram-positive and Gram-negative bacteria and selected protozoa. Competitive inhibitor of peptide formation in large 50S ribosomal unit. Orally active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ivermectin, Positive allosteric modulator of alpha7 nicotinic acetylcholine receptors, 50MG
MW 875.1 Da, Purity >96%. Positive allosteric modulator of α7 neuronal nicotinic acetylcholine receptor. Allosteric effector of P2X₄ receptors. Antihelmintic. Modulates glutamate- and GABA-activated chloride channels. Potentiates glycine-gated currents at low concentrations (30 nM).
The product is subject to the following: Abcam Restricted Use Statement
Abcam D-erythro-Dihydrosphingosine-1-phosphate, sphingosine 1-phosphate receptor ligand, 5MG
MW 381.5 Da, Purity >98%. Sphingosine 1-phosphate (S1P) receptor ligand (Ki = 15 nM). May be used as negative control for intracellular effects of S1P (ab141748). Anti-fibrotic effect in fibroblasts.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Pa x illine, Ca2+-activated K+channel blocker, 5MG
MW 435.6 Da, Purity >98%. Potent high-conductance Ca2+-activated K+channel blocker (Ki = 2 nM, α-subunit BKCa)Inhibits sarco/endoplasmic reticulum Ca2+-ATPase (IC50 = 5 - 50 μM). Shows anticonvulsant effects *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Dihydroxyacetone Phosphate (DHAP) Assay Kit (Fluorometric)
Dihydroxyacetone Phosphate (DHAP) Assay Kit (Fluorometric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cellular Antioxidant Assay Kit
Cellular Antioxidant Assay Kit
The product is subject to the following: Abcam Restricted Use Statement
Abcam Factor Xa Inhibitor Screening Assay Kit (Fluorometric)
Factor Xa Inhibitor Screening Assay Kit (Fluorometric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam MDR Assay Kit (Fluorometric)
MDR Assay Kit (Fluorometric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam 7 AAD Staining Solution
7 AAD Staining Solution
The product is subject to the following: Abcam Restricted Use Statement
Abcam NADNADH Assay Kit (Fluorometric)
NADNADH Assay Kit (Fluorometric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Beta Galactosidase Detection Kit (Fluorometric)
Beta Galactosidase Detection Kit (Fluorometric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Metronidazole, Antiparasitic and antibacterial compound, 25G
MW 171.15 Da, Purity >99%. Nitroimidazole compound with antiparasitic and antibacterial activity. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement